The 3rd presentation of APASL-WGO Virtual Summit is available on YouTube!
Topic: “Selection of treatment modalities in patients infected with chronic HBV in COVID-19 pandemic era [antivirals or interferons]”
Speaker: Dr. Tawesak Tanwandee
You can see the whole slides below the video.

What's New

2025/10/28
Please check out our Guideline page !!

Please check out our Guideline page from the following URL !! Guidelines
2025/10/24
The B-Together study explores the potential of bepirovirsen in modulating immune responses to enhance the clearance of HBV-infected hepatocytes.

The B-Together study explores the potential of bepirovirsen in modulating immune responses to enhance the clearance of HBV-infected hepatocytes. This … [Read more]
2025/10/23
This cross-sectional analysis emphasizes the importance of integrated care approaches in managing patients with MASLD and related comorbidities.

Emerging data from the Paracelsus 10,000 Study reveal a significant association between depression and metabolic dysfunction-associated steatotic liver disease (MASLD), … [Read more]
2025/10/21
Do the therapeutic vaccines hold hope for the treatment of hepatitis B ?

Emerging data from the Paracelsus 10,000 Study reveal a significant association between depression and metabolic dysfunction-associated steatotic liver disease (MASLD), … [Read more]
2025/10/20
Please check out the latest article on Hep I !!

Understanding the stage-specific impact of portal hypertension is crucial in optimizing surgical outcomes for hepatocellular carcinoma (HCC). This study provides … [Read more]

What's New